2026-11-09 · 2026-11 / week-2
SHO’s Higher FFO Guide Still Does Not Clear a 10% Base Case
SHO’s Higher FFO Guide Still Does Not Clear a 10% Base Case
Classification: Reject / no-trade screen. Sunstone’s Q3 RevPAR rose 11.4%, Adjusted FFO per diluted share rose 17.6%, and the company raised its FY26 Adjusted FFO/share range. But the $12.52 Nov. 6 reference price already equals 12.33× the guide midpoint. A transparent four-month sensitivity gives a flat base and a 12.1% adverse price case; the base reward is below 10%, while the downside exceeds 5%. The long fails 10/5 even before execution costs.
Run time: Nov. 9, 2026, 00:26 Singapore time
Market observation: SHO regular-session daily close of $12.52 on Nov. 6, 2026; reference only. U.S. markets are closed Sunday in New York.
Scope: U.S.-listed long opportunities only. No broker order is authorized.
Opportunity Ranking
Ranked by information value. None qualifies as a long.
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sunstone Hotel Investors (SHO) | Long screen | $12.52 equals 12.33× the $1.015 FY26 Adjusted FFO/share midpoint. The guide rose, but no >10% base follows without a rerating or unissued FY27 growth. | High: Nov. 6 SEC results and 10-Q; Nov. 6 close. | FY26 results and next-year outlook; exact report date not verified. The declared $0.09 dividend pays Jan. 15. | Company repurchases are verified; current holder, short and fund-flow positioning is unknown. | Reject: flat base, -12.1% bottom price stress, and -0.7% weighted return including the declared dividend before costs. | NYSE common stock; current quote, spread, depth, venue quality, volume quality and exit capacity unverified. | Hotel values and RevPAR are cyclical; the guide includes a large Andaz Miami Beach contribution and the GAAP profit includes a hotel-sale gain. |
| 2 | IAMGOLD (IAG) | Long screen | $18.76 close, +7.20%; Q3 revenue rose 21% as realized gold prices rose 22%, while gold sales volume fell about 1.3%. The $525M Côté royalty repurchase has not closed. | High: Nov. 5 Q3 release and Nov. 6 issuer quote. | Expected December royalty closing, effective Jan. 1, 2027; Côté mine-plan update expected in Q4. | $135M of Q3 share repurchases are reported; broader current positioning is unknown. | Reject: gold-price, capex and royalty-payback exposure leaves no credible -5% adverse bound. | NYSE common stock; no live execution evidence. | A large cash outlay is justified only if the royalty savings exceed the capital cost through the mine life. |
| 3 | Five9 (FIVN) | Long screen | $28.12 close, -17.63%; Q3 revenue grew 13% and subscription revenue 16%, but gross margin fell and FY26 non-GAAP EPS guidance was reduced about 2%. | High: Nov. 5 SEC release/10-Q and Nov. 6 close. | Level AI acquisition expected to close by FY26 year-end; Q4/FY26 results follow. | Investor positioning not verified; event volume alone is not flow evidence. | Reject: a sharp gap does not provide a bounded downside or independently supported +10% base. | Nasdaq common stock; current execution data unverified. | A $325M cash acquisition is near half its $697.7M cash/investment pool; $747.5M of 2029 convertibles, margin pressure and uncertain AI returns remain. |
| Control | SPDR S&P 500 ETF (SPY) | Long control | $735.29 close, +0.31%; broad beta only, with no issuer-specific catalyst in this screen. | High: Nov. 6 historical daily row. | None specific. | Broad-market flow, not single-name positioning. | No differentiated 10/5 case. | Broad ETF; current execution gates not checked. | Market beta alone is not a mispricing. |
Selected opportunity: SHO is the most informative rejected candidate, not the best executable opportunity.
Why this one now: The Nov. 6 release lets us separate a reported-profit rebound, recurring hotel funds from operations, an actual buyback, and the cash from a hotel disposition.
What should surprise the reader: Sunstone’s $38.7M common-stock profit included a $31.5M pretax gain on selling Hyatt Regency San Francisco. Yet the more relevant Adjusted FFO also rose 17.1% in dollars and 17.6% per diluted share. The quarter was genuinely better, but the FY26 per-share guide midpoint increased only 6.3% and already reflects fewer expected shares.
Why This Is a Fresh Evidence Boundary
The current archive has no standalone SHO article or signal. This screen uses the Nov. 6 Q3 release, the Sept. 30 10-Q, completed repurchases through Nov. 5, and the first regular-session close after the release. It does not treat the reported net-income swing as a recurring operating run rate or the issuer’s “private market value” description as an independent appraisal.
The Market Price
StockAnalysis/S&P Global and FinanceCharts both show a $12.52 Nov. 6 daily close, up 1.38%, with a $12.59 open, $12.60 high, $12.19 low and 2,746,548 shares traded. ChartExchange’s 3:59:59 p.m. EST quote tile also showed $12.52, but its completed historical row lists $12.45 and +0.81%. I use the $12.52 close supported by two daily-history sources and preserve the ChartExchange row as a conflict; the marks are not averaged. [3–5]
The 10-Q reports 176.575 million common shares outstanding on Oct. 30. Multiplying by the Nov. 6 close gives about $2.21 billion of basic common-equity value, before preferred claims; the dates differ by one week. [2]
The Nov. 5 close of $12.35 preceded Sunstone’s scheduled pre-market Nov. 6 results. The next close was $12.52, up 1.38%. The report-day volume and price move do not identify who bought, why they bought, or whether the stock is crowded. [13]
The Setup
Sunstone owns 13 hotels with about 6,200 rooms. The Q3 portfolio RevPAR rose 11.4% and Total RevPAR 10.5%; excluding Andaz Miami Beach, those increases were 10.3% and 9.6%. For FY26, however, management says Andaz is expected to contribute about 450 basis points to RevPAR and Total RevPAR growth. That contribution reflects a hotel returning from renovation, not a repeatable 450-basis-point annual growth rate. [1]
The market pays about 12.33× the $1.015 midpoint of the FY26 Adjusted FFO/share guide. This is a public-guide ratio, not an analyst consensus multiple or fair-value estimate. I did not use a current independent consensus model or hotel-NAV appraisal, so I make no claim that $12.52 is above or below intrinsic value.
The Operating and Cash Bridge
Q3 net income attributable to common stockholders was $38.7M, versus a $2.9M loss in Q3 2025. The 10-Q attributes $31.489M of the current-quarter result to a gain on the Hyatt sale. FFO attributable to common stockholders was $37.150M and Adjusted FFO was $37.176M; the asset-sale gain is removed in the FFO reconciliation. Adjusted FFO rose 17.1% year over year, while Adjusted FFO per diluted share rose 17.6% to $0.20. This is operating progress, not just a sale gain. [1, 2]
The updated FY26 Adjusted FFO/share range is $1.00–$1.03, midpoint $1.015, up from $0.93–$0.98, midpoint $0.955. The per-share midpoint rose 6.3%. Total Adjusted FFO guidance moved from $174M–$184M to $184M–$189M, a midpoint increase from $179M to $186.5M, or 4.2%. The expected diluted-share count fell from 187.0M to 183.5M, down 1.9%. These are company targets, not realized results. [1]
The $31.5M Hyatt sale gain was not free cash flow. In the first nine months, operating cash flow was $161.2M, renovation and other portfolio spending was $76.6M, and net investing cash flow was positive $200.8M amid hotel dispositions. Net financing cash use was $229.8M. As of Sept. 30, the company had $236.5M unrestricted cash, $81.4M restricted cash and $955.0M of debt. A simple debt-less-unrestricted-cash calculation gives $718.5M net funded debt before preferred claims; it is not a company-defined leverage measure. There were no amounts drawn on the $500M credit facility. [2]
Sunstone repurchased 9.368M common shares during Q3 at an average $10.99 for $103.0M. Its release reports 13.749M shares bought for $143.4M from the start of the year through Nov. 5; the 10-Q reports the same share count and $143.7M paid through Sept. 30. The $0.3M cash discrepancy is unresolved. The current $12.52 reference is 13.9% above the Q3 average purchase price and 20.0% above the release’s YTD average of $10.43. Completed buybacks reduced the denominator, but neither the price paid nor management’s private-market-value claim sets a floor. [1, 2]
The Mispricing
The strongest long argument is supported by fresh evidence: RevPAR improved across the portfolio, Adjusted FFO per share rose, the full-year guide moved higher, debt maturities are staggered, and the company completed common-stock repurchases. The strongest skeptical reading is also specific: reported GAAP profit includes an asset-sale gain; FY26 guide growth is 6.3% per share and partly reflects the lower expected denominator; about 450 basis points of annual RevPAR growth is tied to Andaz Miami Beach; and operating cash alone did not fund all repurchases, dividends, capex and hotel investments during the first nine months.
At $12.52, the quote equals 12.33× the FY26 Adjusted FFO/share midpoint. If that multiple holds, a 10% share-price gain requires $1.1165 of FFO per share, 10.0% above the midpoint and 8.4% above the guide’s upper end. If FFO stays at $1.015, the multiple must rise to 13.57×, 10% above the current implied multiple. Neither input is in current company guidance. The price therefore gives no evidence-backed +10% base case.
Positioning
Issuer buying is observable: Sunstone repurchased 9.368M common shares in Q3 and reported 13.749M year-to-date through Nov. 5. This establishes company demand and a lower share count, not the identity, holding period or conviction of other investors. Current beneficial ownership, short interest, fund flows and dealer exposure were not verified. Positioning evidence is partial, not proof of crowding or forced buying.
Catalyst Path
| Step | State and timing | Observable test | Failure or delay |
|---|---|---|---|
| Declared common dividend | Authorized Nov. 5 at $0.09/share; record date Dec. 31 and payment date Jan. 15, 2027. | Verify the payment and subsequent board decision; future dividends are not declared. | A board can change future payments; this distribution is only 0.72% of the current reference price. |
| FY26 results and next-year outlook | Expected after year-end; no exact report date or FY27 FFO target verified. | Compare actual Adjusted FFO, RevPAR excluding Andaz, renovation spend, disposition proceeds, share count and debt with the current guide. | Lower FFO, a slower hotel demand trend or continuing asset-sale dependence weakens the per-share growth case. |
| Portfolio capital decisions | Management may continue dispositions, renovations, acquisitions or repurchases; no future amount is committed by the current release. | Track completed sale prices, resulting room/FFO base, actual buyback price and cash remaining after capex and dividends. | Asset sales can improve near-term cash while reducing future hotel earnings; buybacks can consume liquidity without making a price floor. |
The cheapest falsification test is the FY26 cash and FFO reconciliation: check whether the higher guide converts into recurring common FFO after removing property gains, and whether operating cash covers maintenance capital and distributions without relying on further hotel sales.
Why the Stock Can Move More Than 5%, Yet the Long Fails
Full-year results can reset the hotel multiple, and lodging demand can change with business travel, group bookings and consumer spending. The model’s top case is above 10%, but it requires both the high end of FFO guidance and a higher multiple. The highest-probability base is essentially flat before the declared dividend. The adverse case is more than 5% down. Volatility does not create a qualifying long by itself.
10/5 Asymmetry Gate
The reference-only model’s base price return is 0.0%; including the declared $0.09 dividend paid by Jan. 15, the total base return is about +0.7%. Its bottom price case is -12.1%, or -11.4% after that dividend. Base-to-adverse reward/risk is 0.00:1 on price, or 0.06:1 including the fixed distribution. Probability-weighted total return is -0.7% before spread, slippage and other costs. The long fails the +10% base and -5% adverse tests. Missing live execution evidence is a separate block; it does not change the Reject classification.
Price Target and Probability Map
This is a 120-calendar-day, reference-only sensitivity through Mar. 9, 2027. It uses target price = FY26 Adjusted FFO per diluted share × assumed price/FFO multiple. Current implied multiple is $12.52 ÷ $1.015 = 12.33×. The top uses the high end of the company’s FY26 guide and a 13.5× multiple; the base uses the guide midpoint and today’s multiple; the bottom uses the guide low end and an 11× compression stress. The multiples are analyst assumptions, not peer-derived or calibrated estimates. The $0.09 declared common dividend is shown separately as cash, not added to the target prices. No FY27 FFO forecast is assumed.
The subjective weights reflect the company’s current guide and the gap between recurring FFO and one-off/property-dependent cash: 50% for the midpoint at the current multiple, 20% for the upper guide plus modest rerating, and 30% for the lower guide plus compression. These are not observed frequencies. Hotel-level liquidity, asset prices, debt and a future FY27 FFO path could produce outcomes outside the range.
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 20% | $13.91 | +11.1% price; +11.8% including declared dividend | 120 days, through Mar. 9, 2027 | FY26 Adjusted FFO reaches $1.03 and the share multiple expands to 13.5×. | Medium-low: upper guide is issuer-stated; rerating is assumed. |
| Base Case | 50% | $12.52 | 0.0% price; +0.7% including declared dividend | 120 days, through Mar. 9, 2027 | Adjusted FFO reaches $1.015 and the 12.33× multiple holds. | Medium: guide is current; no FY27 outlook or independent valuation is included. |
| Bottom Case | 30% | $11.00 | -12.1% price; -11.4% including declared dividend | 120 days, through Mar. 9, 2027 | Adjusted FFO reaches the $1.00 guide floor and the multiple contracts to 11×. | Low: the compression is a stress assumption, not a price floor. |
| Invalidation | n/a | Rebuild from new filings and the market quote | n/a | Before any new research | FY27 FFO and property/cash disclosures support a base return ≥10%, credible adverse ≤5%, and positive value after costs. | Future evidence required. |
Probability-weighted expected value: $12.34 price-only (-1.4%); $12.43 including the declared $0.09 distribution (-0.7%), both before costs.
Current market level and timestamp: $12.52 at the Nov. 6, 2026 regular close, 21:00 UTC; reference only.
Primary instrument: Unlevered NYSE common stock, only if a future review qualifies it.
10/5 favorable base move: 0.0% price-only; +0.7% including the declared dividend.
10/5 credible adverse move: -12.1% price-only; -11.4% after the declared dividend in the stress case.
10/5 measurement basis: Reference-only; no executable entry.
10/5 status: Reject / no trade.
Confidence: Low; no peer-multiple calibration, FY27 FFO guide or live execution data.
The sensitivity shows which input matters. At 12.33×, a +10% base requires $1.1165 FFO/share, above both ends of the current guide. At $1.015 FFO/share, it requires 13.57×. At the $1.00 guide floor, the stress price falls to $11 at 11×. A deeper hotel-market or asset-value decline could go below the model; no historical low is a floor.
The Kill Shot
The strongest counterargument is that Q3 growth was broad enough to matter: RevPAR excluding Andaz rose 10.3%, Adjusted FFO grew 17.1%, and completed buybacks lifted per-share economics. The Hyatt sale gain does not erase this operating evidence because Adjusted FFO removes the gain. If the portfolio keeps those trends after Andaz’s comparison benefit fades, the 2026 guide may prove conservative.
The fragile assumption in the rejection is that 12.33× the current FFO guide is a reasonable anchor for the next four months. A return to 13.5× and $1.03 FFO produces an 11.1% price gain, but no current evidence establishes that valuation as likely or downside as bounded. The strongest reason the model can understate upside is persistent RevPAR growth and capital redeployment at attractive prices. The strongest reason it can understate risk is that hotel asset values and demand can fall together while the company retains debt and renovation commitments.
What Would Prove This Screen Wrong
Reopen the long only when filed FY26 results separate recurring FFO from sale proceeds, FY27 guidance supports a base return of at least 10% from a fresh quote, and the adverse scenario is no worse than 5% without relying on a stop. Check that property sales and repurchases raise per-share value after lost hotel earnings, interest income, maintenance investment and preferred claims. A lower share price alone does not invalidate the screen or create a floor.
Risk Audit
- What the market may already know: The Hyatt sale, its $31.5M gain, strong Q3 RevPAR, revised guide, completed common buybacks and $0.09 dividend were public by Nov. 6.
- Operating risk: A 13-hotel portfolio is exposed to business, group and leisure demand. Andaz adds about 450 basis points to FY26 RevPAR growth; that comparison benefit will not repeat indefinitely.
- Cash and capital risk: Nine-month CFO was $161.2M while renovations were $76.6M; net investment cash flow was positive amid dispositions. Share repurchases, preferred buybacks and dividends used cash. Future hotel sales are not operating cash.
- Claims risk: Sept. 30 debt was $955.0M, unrestricted cash $236.5M and restricted cash $81.4M. The company had no credit-facility draw and no debt maturities until January 2028, but net debt remains material and preferred shares rank ahead of common equity.
- Model risk: Target FFO and multiples are scenario inputs. The 11× stress is not calibrated, preferred capital is not a common-equity price floor, and the StockAnalysis/ChartExchange daily-row conflict is unresolved.
- Gap and liquidity risk: Weekend research has no fresh quote; spread, depth, venue quality, volume quality and exit liquidity are unverified. A gap or halt can pass any assumed stop.
- Execution state: Entry remains null and execution is disabled. New evidence would require a new review, not automatic arming.
Best Trade Strategy
No trade. Do not turn the $12.52 reference, $10.99 quarterly repurchase average, 52-week markers or model targets into an order or price floor. No options, leverage, margin or market-order strategy was evaluated. Reassess after FY26 results and FY27 guidance, using a fresh regular-session quote and a reconciled hotel-sale, FFO, debt and share-count bridge.
Sources
- Sunstone Q3 2026 results, updated FY26 outlook and repurchases — SEC Exhibit 99.1, Nov. 6, 2026
- Sunstone Form 10-Q for quarter ended Sept. 30, 2026 — SEC
- SHO historical daily prices — StockAnalysis/S&P Global
- SHO historical daily prices and close-time quote — ChartExchange
- SHO historical prices — FinanceCharts
- IAMGOLD Q3 2026 results and Côté royalty transaction — company release, Nov. 5, 2026
- IAG official stock performance and Nov. 6 quote
- Five9 Q3 2026 results and FY26 guidance — SEC Exhibit 99.1, Nov. 5, 2026
- Five9 Form 10-Q for quarter ended Sept. 30, 2026 — SEC
- Five9 Q2 2026 results and prior FY26 guide — SEC Exhibit 99.1, Aug. 6, 2026
- FIVN historical daily prices — StockAnalysis/S&P Global
- SPY historical daily prices — ChartExchange
- Sunstone Q3 2026 release schedule — company IR, Sept. 18, 2026
Research Quality Scorecard
| Criterion | Score | Evidence and deduction |
|---|---|---|
| Market disagreement | 3/5 | FFO guide and price ratio are explicit; no independent consensus or NAV estimate. |
| Evidence base | 4/5 | Fresh SEC results, 10-Q, issuer repurchase and market history; quote-row conflict remains. |
| Positioning and flows | 3/5 | Completed issuer buybacks are direct; wider investor positioning is unknown. |
| Catalyst path | 3/5 | FY26 close and declared dividend have observable dates; report date and FY27 guide timing are unverified. |
| Payoff architecture | 3/5 | FFO model is transparent, but target multiples and scenario weights are subjective. |
| Invalidation discipline | 4/5 | FFO, guide, sale and cash tests are explicit; no 5% bound is claimed. |
| Differentiated insight | 4/5 | Separates genuine recurring FFO improvement from the property gain, repurchase denominator and Andaz comparison effect. |
| Client value | 4/5 | Identifies why the raised guide is not yet a 10/5 long and what evidence could change the decision. |
| Total | 28/40 | Publishable no-trade note; the score does not override the failed 10/5 gate. |
Bottom Line
Sunstone delivered stronger hotel operations, per-share FFO and executed buybacks. At $12.52, the public FY26 FFO midpoint still supports only a flat reference base unless the multiple expands; the explicit stress case falls more than 5%. The $31.5M sale gain, hotel-cycle exposure, cash-funded distributions and missing FY27 guide leave no responsible long edge. Reject and wait for the full-year cash and FFO bridge.
AI Illustration Prompt
Editorial illustration: a single coastal resort hotel at dusk, half its windows warmly lit and half still under renovation; in the foreground, a clean paper ledger separates “Hotel FFO,” “Sale gain,” “Buyback” and “Debt,” with one brass hotel key resting across the dividing line. Show the open sea as a quiet reminder that occupancy can turn with demand, not as a dramatic storm. Restrained charcoal, limestone, muted gold and deep navy palette, no logos, no upward chart, no price arrows, ample negative space, subtle readable “The Mispricing Desk” watermark.